HIV Diagnostics Market Key Information By Top Key Player Merck, Abbott, Biomerieux, Sysmex Partec, Siemens Healthineers, PointCare Technologies, Alere, Qiagen, Cepheid, Roche Diagnostics, Hologic, Beckman Coulter Biomedical

The global HIV diagnostics market is chiefly driven by upsurge in the incidence rate of HIV/AIDS, the rising number of blood transfusions, and increasing percentage of blood donations. Various benefits associated with the point-of-care equipment and test kits through which patients can be diagnosed even outside a pathology setting would propel the market trends in the future.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467735/

Globally, about 36.9 million individuals were suffering from HIV in the year 2017, as per the World Health Organization. The HIV can be diagnosed by saliva test, blood test, and viral load test. However, medical experts consider that highly accurate test results can be generated through enzyme-linked immunosorbent assay or ELISA test in the preliminary stages and through western blot process in later stages.

Agile initiatives by government bodies and non-profit organizations to monitor and manage the spread of HIV would further advance revenue prospects of the HIV diagnostics market. Each year, Magic Johnson Foundation, a distinguished philanthropic organization, hosts a series of free of charge HIV/AIDS testing programs to increase awareness about HIV/AIDS. The Foundation’s HIV/AIDS initiative endeavors to make HIV testing a routine task to eventually decline the HIV infection incidence rate.

U.S. HIV diagnostics market held the largest revenue in North America valued at USD 876.8 in 2017 and will grow significantly over the forecast timeline. Growth is attributable to increasing prevalence of HIV infection in the country coupled with high awareness among people regarding HIV diagnosis and treatment. Moreover, strong foothold of key industry players in the U.S., and regulatory support coupled with high healthcare expenditure will favor HIV diagnostics business growth.

Moreover, HIV point of care test (POCT) used to provide quick results and approved for screening will accelerate industry growth. Improved access to HIV tests and associated diagnostics will increase adoption of POCT during forthcoming years. Growing need to combine these technologies efficiently and cost-effectively into existing laboratory networks and clinical algorithms will favor HIV diagnostics business growth. However, low penetration of HIV diagnostics in under-developed or poorly resourced countries due to limited access to lifesaving treatments may impede the industry growth in the foreseeable future.

Viral load testing segment is projected to experience lucrative CAGR of 9.2% over the forecast period. Growing need for early detection of HIV infection and monitoring treatment progress will fuel viral load testing market growth. Growing technological advancements such as branched DNA (bDNA), nucleic acid sequence-based amplification assay (NASBA) and reverse transcription polymerase chain reaction (RT-PCR) to determine blood HIV viral load will augment the segment growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467735/

Antibody tests segment accounted for more than 33% revenue share in 2017 and is expected to show considerable growth over forecast period. The growth is attributable to rising incidences of HIV infection across the globe. Availability of several antibody tests such as rapid and home tests for early HIV detection will further increase its adoption over the coming years. Rising awareness among people regarding regular blood tests and increasing prevalence of HIV symptoms will favor business growth.

South Africa HIV diagnostics market is estimated to grow at a lucrative CAGR of 8.8% during the analysis period. High prevalence of AIDS in South African population will offer several growth opportunities for business growth. According to the UNAIDS, more than 7 million people were living with HIV infection in 2017. Initiatives undertaken by various government and non-governmental organizations to create awareness and increase HIV diagnosis in the country will further accelerate industry growth.

Some of the players operating in HIV diagnostics market are Siemens Healthineers, Merck, Sysmex Partec, PointCare Technologies, Alere, Qiagen, Apogee Flow Systems, Cepheid, Roche Diagnostics, Hologic, Beckman Coulter Biomedical, ChemBio Diagnostics, Abbott, Biomerieux and BD Biosciences. Prime focus of the industry players is on inorganic strategies including acquisitions, merger, partnership and new product launch to strengthen their existing product portfolio and maintain market position.

Table of Content:

Chapter 1. HIV Diagnostics Market Methodology and Scope

Chapter 2. HIV Diagnostics Market Executive Summary

Chapter 3. HIV Diagnostics Industry Insights

Chapter 4. HIV Diagnostics Market, By Product

Chapter 5. HIV Diagnostics Market, By Region

Chapter 6. HIV Diagnostics Market Company Profiles

Outer Scope: With increasing HIV awareness among masses, early-stage disease detection can be made highly possible. Early diagnosis allows patients suffering from HIV to start treatment sooner, which can, in turn, increase their chances of living a healthy and long life. Early detection also reduces the risks of developing AIDS, transmitting HIV further, and contracting tuberculosis. The fear of probable infection and precautionary testing by the masses to stay updated with their HIV status would add impetus to the HIV diagnostics market in the years to come.

For more information on this report at: https://www.marketstudyreport.com/reports/hiv-diagnostics-market/?utm_source=OPR-SP
Related Report:

Global HIV Diagnostics Market Size, Status and Forecast 2025

This report studies the global HIV Diagnostics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global HIV Diagnostics market by companies, region, type and end-use industry.

https://www.marketstudyreport.com/reports/global-hiv-diagnostics-market-size-status-and-forecast-2025?utm_source=RR-SP

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.